Children's Mercy | GenomeWeb

Children's Mercy

When it comes to fully enrolling infants in sequencing studies, parental enthusiasm sometimes seems to wane due to logistical considerations and privacy concerns. 

Stephen Kingsmore

As president and CEO of the Rady Pediatric Genomics and Systems Medicine Institute, Kingsmore will be working toward adopting genomics to transform pediatric care.

The researchers increased the test's sensitivity for nucleotide variants from less than 96 percent to 99.5 percent and reduced the time to provisional results from 50 hours to 26 hours.

The retrospective study, by researchers at Children's Mercy Kansas City, suggests the STAT-seq test has clinical utility in some patients.

The partners will collaborate on pediatric oncology research, with a goal of earning an NCI designation of Comprehensive Cancer Center.

baby

The study appears to be the only one of four that has launched 15 months after the awards were made, which may or may not be related to FDA oversight of the projects.

Researchers also plan to launch a prospective randomized clinical trial to test the effectiveness of whole-genome sequencing compared to the standard of care.

Children's Mercy Hospital is poised to update its rapid whole-genome sequencing protocol, known as STAT-seq, in an effort to bring the time needed for genome sequencing and analysis down to around 24 hours.

Children's Mercy Hospital has launched a next-generation sequencing-based test that assesses the coding regions of 514 genes implicated in more than 750 severe childhood-onset diseases.

Children's Mercy Hospital has launched its Targeted Gene Sequencing and Custom Analysis, or TaGSCAN, test to diagnose pediatric genetic diseases.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.